Manufacturing

Accord operates 2 significant EU cGMP approved manufacturing sites, SEZ and Matoda. Oral solid dose capabilities include anti-cancer and immunosuppressant drugs, as well as regular tablets and capsules and effervescent and pellet formulations.

Parenteral capabilities include regular and cytotoxic solution and lyophilised vials as well as regular and controlled drug ampoules.